Home >> Blog >> Crop Life Science LTD. IPO - Review, Valuation & Todays GMP
Crop Life Science LTD. IPO - Review, Valuation & Todays GMP
Table of Contents
- Crop Life Science Limited - Complete Overview
- What does the company do?
- Company Products
- IPO Overview
- Company Financial
- Objective of the Issue
- Promoters and Management of Crop Life Science Limited
- Peer Comparison
- IPO's Valuations
- Dividend Policy
- IPO's Strengths
- IPO Weaknesses
- IPO GMP Today
- Conclusion
Crop Life Science Limited - Complete Overview
Founded in 2006, Crop Life Science Limited is a prominent player in the agrochemical sector, dedicated to the production, distribution, and promotion of a diverse portfolio of agrochemical chemical formulations. These chemicals encompass Pesticides and Micro Fertilizer, with a comprehensive range of pesticides including Insecticides, Fungicides, Herbicides, and Weedicides.
The company has expanded its global footprint by exporting its pesticides and Micro Fertilizer to multiple countries, such as Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, Sudan and others.
Its manufacturing unit is situated in GIDC Ankleshwar (Gujarat) covering an area of approximately 5831.10 Square Meters, the company holds registrations with the Central Insecticides Board ("CIB"). It boasts approvals from the Directorate of Agriculture, Government of Gujarat, as well as the Gujarat Pollution Control Board ("GPCB").
Currently, the company offers a wide spectrum of more than 85 agrochemical products.
What does the company do?
Crop Life Science Limited operates as an agrochemical enterprise, specializing in the production, distribution, and promotion of a diverse array of agrochemical formulations.
Company Products
The company offers a wide range of over 85 agrochemical products.
IPO Overview
The IPO date for the offering spans from August 18th to August 22nd, 2023. This IPO operates under a fixed-price issuance model. The total issue size of the IPO comprises 5,140,000 shares, which collectively amount to Rs.26.73 Crores.
The IPO share price has been set at Rs.52 per share, as determined by the company. Each lot of the IPO consists of 2000 shares, with retail investors eligible to bid for a maximum of 1 lot.
In terms of allocation for the upcoming IPO, the company has designated 50% of the overall offering for retail investors, while the remaining 50% is allocated to other investors.
Crop Life Science Limited IPO timetable (Tentative)
EVENTS |
DATE |
IPO Opening Date |
18 August 2023 |
IPO Closing Date |
22 August 2023 |
IPO Allotment Date |
25 August 2023 |
Refund initiation |
28 August 2023 |
IPO Listing Date |
30 August 2023 |
Crop Life Science Limited IPO Details
IPO Opening & Closing Date |
18 August to 22 August 2023 |
Face Value |
Rs. 10 per share |
Issue Price |
Rs. 52 per share |
Lot Size |
2000 Shares |
Price of 1 Lot |
Rs. 104,000 |
Issue Size |
5,140,000 Shares (aggregating up to Rs. 26.73 Cr) |
Offer for Sale |
NA |
Fresh Issue |
5,140,000 Shares (aggregating up to Rs. 26.73 Cr) |
Listing at |
NSE SME |
Issue Type |
Fixed Price Issue IPO |
Registrar |
Purva Sharegistry India Pvt. Ltd. |
Crop Life Science Limited IPO Lot Details
Minimum Lot Investment (Retail) |
1 Lot |
Maximum Lot Investment (Retail) |
1 Lot |
Minimum Lot Investment (HNI) |
2 Lot |
Crop Life Science Limited IPO Reservation
Other Investors Portion |
50% |
Retail Portion |
50% |
Company Financial
Amount in Lakhs
Period |
FY 21 |
FY 22 |
FY 23 |
Total Assets |
8630.18 |
9457.75 |
10471.64 |
Total Revenue |
11950.18 |
10238.92 |
12323.43 |
PAT |
370.46 |
281.41 |
436.66 |
Net Worth |
3287.06 |
3526.33 |
4038.51 |
Reserve & Surplus |
2114.88 |
2401.86 |
2838.51 |
Total Borrowings |
1747.29 |
2093.03 |
2682.32 |
Sales breakup of for Fiscal 2023, Fiscal 2022 and Fiscal 2021
(Amount in Lakhs)
Particular |
2022-23 (up to 28.02.2023) |
2021-22 |
2020-21 |
Domestic Sales |
12066.77 |
9921.67 |
11599.52 |
Export Sales |
186.49 |
273.1 |
292.76 |
Revenue from Operations |
12253.26 |
10194.77 |
11892.28 |
Objective of the Issue
The funds will be allocated to achieve the following objectives:
- Fulfilling working capital needs.
- Supporting general corporate endeavours.
- Covering expenses related to the public issue.
Promoters and Management of Crop Life Science Limited
Among the company's promoters are Rajesh Lunagariya, aged 53 and serving as the MD, and Ashvin Lunagaria, aged 58, who holds the position of Promoter and Whole Time Director.
Pre-issue Promoters Holding |
100.00% |
Post-issue Promoters Holding |
70.01% |
Peer Comparison
The following are the listed peers as per the Crop Life Science Limited DRHP
Company Name |
CMP |
EPS |
P/E Ratio |
Total Income (in Lakhs) |
Crop Life Science Limited |
52 |
2.35 |
22.13 |
10238.92 |
Aristo Bio-Tech and Lifescience Limited |
72.85 |
2.87 |
25.38 |
16603.29 |
Dharmaj Crop Guard Limited |
200.60 |
11.62 |
17.26 |
39628.80 |
Heranba Industries Limited |
370.00 |
47.25 |
7.83 |
146972.30 |
IPO's Valuations
With an EPS of Rs. 2.35 per share and a P/E ratio of 22.13, the calculation yields an IPO valuation of Rs. 52 per share.
Dividend Policy
The company has not paid any dividends in the past; however, it may adopt a prudent dividend policy in the future based on its financial performance and other factors.
IPO's Strengths
- Diverse and extensive product range.
- Well-established distribution network.
- Seasoned Promoters, Directors, and Management team.
- Strategic factory location.
- Quality assurance.
IPO Weaknesses
- There are outstanding litigations by and against the Company.
- Contingent liabilities may impact financial position.
- Promoter group companies' similar facilities could create a conflict of interest.
- Necessity to secure and renew government registrations, licenses, and permits.
- Vulnerability to climatic conditions and the cyclical nature of business.
- Intellectual property rights protection registrations pending.
- The company has no long-term supply agreements for key raw materials.
- There have been instances of GST Returns and EPF Payments delays in the past.
- Potential impact from alternative crop protection measures, such as biotechnology products, pest-resistant seeds or genetically modified (“GM”) crops.
- Non-compliance with safety, health, and environmental regulations could have adverse effects.
- Overseas customers require product approval/registration in their respective countries.
- Business dependence on a few customers and suppliers.
- Manufacturing Units subject to GPCB inspections.
- The company faces competition from both Domestic and international competitors.
IPO GMP Today
LatestGMP of Crop Life Science Limited is Rs. 5
Conclusion
Crop Life Science Limited boasts a diverse product range and maintains a robust global distribution network. Despite demonstrating commendable recovery post the fire incident in FY 22, the company operates within a fiercely competitive sector. Therefore, investors should diligently evaluate crucial factors before considering participation in the Crop Life Science Ltd IPO.
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the Company Click Here to Download the DRHP
Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.
Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock market.
Frequently Asked Questions
Crop Life Science Limited is an agrochemical company that manufactures, distributes, and promotes a diverse portfolio of agrochemical chemical formulations. The company is headquartered in GIDC Ankleshwar (Gujarat) and has a manufacturing unit with a capacity of 5831.10 Square Meters.
The IPO size of Crop Life Science Limited is 5,140,000 shares at Rs.52 per share.
The IPO opening date of Crop Life Science Limited is August 18, 2023 and the closing date is August 22, 2023.
The proceeds from the IPO of Crop Life Science Limited will be used to fund working capital requirements, general corporate expenses, and expenses related to the public issue.
The risks associated with investing in the IPO of Crop Life Science Limited include:
- The company is a relatively new company and has not been listed on the stock exchange for a long time.
- The company operates in a cyclical industry and its performance can be affected by factors such as weather conditions and crop prices.
- The company faces competition from both domestic and international players.
Whether or not you should invest in the IPO of Crop Life Science Limited is a decision that you should make after carefully considering all of the risks and rewards. You should consult with a financial advisor before making any investment decisions.